0001415889-23-006301.txt : 20230405 0001415889-23-006301.hdr.sgml : 20230405 20230405170028 ACCESSION NUMBER: 0001415889-23-006301 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230403 FILED AS OF DATE: 20230405 DATE AS OF CHANGE: 20230405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sorg Elaine K. CENTRAL INDEX KEY: 0001832571 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 23803327 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 form4-04052023_050407.xml X0407 4 2023-04-03 0001551152 AbbVie Inc. ABBV 0001832571 Sorg Elaine K. 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 false true false false SVP, US COMMERCIAL OPERATIONS 0 Common Stock, $0.01 par value 2023-04-03 4 M 0 15002 93.50 A 57831 D Common Stock, $0.01 par value 2023-04-03 4 S 0 15002 160.03 D 42829 D Option (Right to Buy) 93.50 2023-04-03 4 M 0 15002 93.50 D 2021-02-20 2030-02-19 Common Stock 15002 0 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.00 to $160.05, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Steven L. Scrogham, attorney-in-fact for Elaine K. Sorg 2023-04-05